Craig says he's cobbling together leftover drugs to make his 10-year-old son's medication last after recently being unable to ...

The oxytocic pharmaceuticals market is expected to grow significantly, nearly doubling in size from USD 133.2 million in 2025 ...

A Fierce Pharma Marketing review of the LinkedIn and Instagram pages of the 20 largest pharmas found that, as of Thursday, ...

The US government, seeking to fend off a drugmaker’s legal challenge over a federal drug price negotiation program, is ...

FYB203 has been approved by the US FDA and UK Medicines and Healthcare products Regulatory Agency for the treatment ...

Being able to reduce our cost of capital demonstrates great confidence, by a group of experienced healthcare investors, in Alvotech’s leadership, our pipeline progress and prospects for near-term ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’ Substack by Kontra. In this ...

PM360 is honored to announce its Lifetime Achievement Recipient—Dr. Sol J. Barer of Teva Pharmaceuticals—who will be recognized at the 17th annual Trailblazer Awards in NYC on September 30.

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines ...

The global allergic rhinitis market is poised for substantial growth from 2025 to 2035, driven by a rise in allergic diseases, and advancements in th ...

If you want to support news that works for Greenwood — make a tax-deductible gift today.